Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 4
2004 2
2005 3
2006 3
2007 3
2008 4
2009 2
2010 2
2011 3
2012 4
2013 3
2014 4
2015 3
2016 1
2017 4
2018 10
2019 15
2020 16
2021 19
2022 16
2023 16
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

125 results

Results by year

Filters applied: . Clear all
Page 1
Biologic Therapy in Rare Eosinophil-Associated Disorders: Remaining Questions and Translational Research Opportunities.
Khoury P, Roufosse F, Kuang FL, Ackerman SJ, Akuthota P, Bochner BS, Johansson MW, Mathur SK, Ogbogu PU, Spencer LA, Wechsler ME, Zimmermann N, Klion AD; International Eosinophil Society Clinical Research Interest Group. Khoury P, et al. J Leukoc Biol. 2024 Mar 8:qiae051. doi: 10.1093/jleuko/qiae051. Online ahead of print. J Leukoc Biol. 2024. PMID: 38457125
S3-Leitlinie Atopische Dermatitis: Teil 2 - Systemische Therapie: S3 guideline Atopic dermatitis: Part 2 - Systemic treatment.
Werfel T, Heratizadeh A, Aberer W, Augustin M, Biedermann T, Bauer A, Fölster-Holst R, Kahle J, Kinberger M, Nemat K, Neustädter I, Peters E, von Kiedrowski R, Schmid-Grendelmeier P, Schmitt J, Schwennesen T, Simon D, Spindler T, Traidl-Hoffmann C, Werner RN, Wollenberg A, Worm M, Ott H. Werfel T, et al. Among authors: simon d. J Dtsch Dermatol Ges. 2024 Feb;22(2):307-322. doi: 10.1111/ddg.15229_g. J Dtsch Dermatol Ges. 2024. PMID: 38361206 Free article.
A Multicenter Long-Term Cohort Study of Eosinophilic Esophagitis Variants and Their Progression to Eosinophilic Esophagitis Over Time.
Greuter T, Straumann A, Fernandez-Marrero Y, Germic N, Hosseini A, Chanwangpong A, Yousefi S, Simon D, Collins MH, Bussmann C, Chehade M, Dellon ES, Furuta GT, Gonsalves N, Hirano I, Moawad FJ, Biedermann L, Safroneeva E, Schoepfer AM, Simon HU. Greuter T, et al. Among authors: simon d. Clin Transl Gastroenterol. 2024 Apr 1;15(4):e00664. doi: 10.14309/ctg.0000000000000664. Clin Transl Gastroenterol. 2024. PMID: 38318864 Free PMC article.
Dupilumab-associated ocular surface disease is characterized by a shift from Th2/Th17 toward Th1/Th17 inflammation.
Thormann K, Lüthi AS, Deniau F, Heider A, Cazzaniga S, Radonjic-Hoesli S, Lehmann M, Schlapbach C, Herzog EL, Kreuzer M, Zinkernagel MS, Akdis CA, Zysset-Burri DC, Simon HU, Simon D. Thormann K, et al. Among authors: simon d. Allergy. 2024 Apr;79(4):937-948. doi: 10.1111/all.16045. Epub 2024 Feb 5. Allergy. 2024. PMID: 38317432 Free article.
S3 Guideline Atopic dermatitis: Part 1 - General aspects, topical and non-drug therapies, special patient groups.
Werfel T, Heratizadeh A, Aberer W, Augustin M, Biedermann T, Bauer A, Fölster-Holst R, Kahle J, Kinberger M, Nemat K, Neustädter I, Peters E, von Kiedrowski R, Schmid-Grendelmeier P, Schmitt J, Schwennesen T, Simon D, Spindler T, Traidl-Hoffmann C, Werner RN, Wollenberg A, Worm M, Ott H. Werfel T, et al. Among authors: simon d. J Dtsch Dermatol Ges. 2024 Jan;22(1):137-153. doi: 10.1111/ddg.15230. Epub 2024 Jan 3. J Dtsch Dermatol Ges. 2024. PMID: 38171719 Free article.
S3 guideline Atopic dermatitis: Part 2 - Systemic treatment.
Werfel T, Heratizadeh A, Aberer W, Augustin M, Biedermann T, Bauer A, Fölster-Holst R, Kahle J, Kinberger M, Nemat K, Neustädter I, Peters E, von Kiedrowski R, Schmid-Grendelmeier P, Schmitt J, Schwennesen T, Simon D, Spindler T, Traidl-Hoffmann C, Werner RN, Wollenberg A, Worm M, Ott H. Werfel T, et al. Among authors: simon d. J Dtsch Dermatol Ges. 2024 Feb;22(2):307-320. doi: 10.1111/ddg.15229. Epub 2023 Dec 31. J Dtsch Dermatol Ges. 2024. PMID: 38161245 Free article.
Baricitinib treatment rapidly improves the four signs of atopic dermatitis assessed by Eczema Area and Severity Index (EASI) clinical subscores.
Wollenberg A, Simon D, Kulthanan K, Figueras-Nart I, Misery L, Tangsirisap N, Spina L, Lu N, Grond S, Eyerich K. Wollenberg A, et al. Among authors: simon d. J Eur Acad Dermatol Venereol. 2024 Apr;38(4):695-702. doi: 10.1111/jdv.19669. Epub 2023 Dec 2. J Eur Acad Dermatol Venereol. 2024. PMID: 38041556 Free article. Clinical Trial.
125 results